NCT02040142View on ClinicalTrials.gov

HIPEC for Peritoneal Carcinomatosis

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

October 13, 2022

Study Completion Date

August 19, 2024

Conditions
Peritoneal CarcinomatosisColorectal CancerAppendiceal CancerPeritoneal MesotheliomaPseudomyxoma PeritoneiGastric Cancer
Interventions
PROCEDURE

HIPEC

DRUG

Mitomycin C

Trial Locations (1)

10461

Department of Surgery, Montefiore Medical Center- Weiler Division, The Bronx

All Listed Sponsors
lead

Albert Einstein College of Medicine

OTHER

NCT02040142 - HIPEC for Peritoneal Carcinomatosis | Biotech Hunter | Biotech Hunter